암환자 섬망의 약물치료
Pharmacological Treatment for Delirium in Cancer Patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: Despite the fact that delirium is a frequent neuropsychiatric disorder in cancer patients, there are, in Korea, no guidelines for the pharmacological treatment of such delirium. This systematic review evaluated the efficacy and safety of some pharmacological interventions and summarized the results. Methods: We searched PubMed, Embase, CINAHL, the Cochrane Library, and the KMbase, targeting from January 1990 to October 2008, using key words. Moreover, we included systematic reviews, meta-analyses, and randomized controlled trial literature in the search. Then, we stratified the trials based on their evidence levels. Results and Conclusion: We identified 13 randomized, controlled studies and 2 case-control studies that met our inclusion criteria. These showed that haloperidol was the medication of choice to treat delirium. In addition, they revealed that atypical antipsychotics have not shown clear superiority with regard to effectiveness as compared to haloperidol. Neither donepezil nor rivastigmine were shown to be effective in preventing or treating delirium.
Abstract
Objectives: Despite the fact that delirium is a frequent neuropsychiatric disorder in cancer patients, there are, in Korea, no guidelines for the pharmacological treatment of such delirium. This systematic review evaluated the efficacy and safety of some pharmacological interventions and summarized the results. Methods: We searched PubMed, Embase, CINAHL, the Cochrane Library, and the KMbase, targeting from January 1990 to October 2008, using key words. Moreover, we included systematic reviews, meta-analyses, and randomized controlled trial literature in the search. Then, we stratified the trials based on their evidence levels. Results and Conclusion: We identified 13 randomized, controlled studies and 2 case-control studies that met our inclusion criteria. These showed that haloperidol was the medication of choice to treat delirium. In addition, they revealed that atypical antipsychotics have not shown clear superiority with regard to effectiveness as compared to haloperidol. Neither donepezil nor rivastigmine were shown to be effective in preventing or treating delirium.
참고문헌 (43)
- Olofsson SM, "A retrospective study of the psychiatric management and outcome of delirium in the cancer patient", Support Care in Cancer, 4, pp.351~357 (1996)
- Weinrich S, "Delirium in the older person with cancer", Cancer, 74(7 Suppl), pp.2079~2091 (1994)
- Pereira J, "The frequency and clinical course of cognitive impairment in patients with terminal cancer", Cancer, 79, pp.835~842 (1997)
- "The cochrane library"[URL]
- "Scottish Intercollegiate Guidelines Network. Sign 50. Guideline developer’s handbook 2008 appendix B"[URL]
- Leonarda M, "Delirium issues in palliative care settings", J of Psychosomatic Research, 65, pp.289~298 (2008)
- Lawlor PG, "Delirium in patients with advanced cancer", Hematol Oncol Clin N Am, 16, pp.701~714 (2002)
- Breitbart W, "A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of deliriumin hospitalized AIDS patients", Am J Psychiatry, 153, pp.231~237 (1996)
- Kalisvaart KJ, "Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study", J Am Geriatr Soc, 53, pp.1658~1666 (2005)
- Kaneko T, "Prophylactic consecutive administration of haloperidol can reduce the occurance of postoperative delirium in gastrointestinal surgery", Yonago Acta Med, 42, pp.179~184 (1999)
- American Psychiatric Association, "Practice guideline for the treatment of patients with delirium", Am J Psychiatry, 156(5 Suppl), pp.1~20 (1999)
- Platt MM, "Efficacy of neuroleptics for hypoactive delirium", J Neuropsychiatry Clin Neurosci, 6, pp.66~67 (1994)
- Tune L, "Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium", Am J Psychia, 149, pp.1393~1394 (1992)
- Practice guideline for the treatment of patients with delirium, "American Psychiatric Association", American Journal of Psychiatry, 156, pp.1~20 (1999)
- Sharma ND, "Torsades de pointes associated with intravenous haloperidol in critically ill patients", Am J Cardiol, 81, pp.238~240 (1998)
- Menza MA, "Decreased extrapyramidal symptoms with intravenous haloperidol", J Clin Psychiatry, 48, pp.278~280 (1987)
- Han CS, "A double-blind trial of risperidone and haloperidol for the treatment of delirium", Psychosomatics, 45, pp.297~301 (2004)
- Hu H, "A prospective random control study comparison of olanzapine and haloperidol in senile delirium", Chongging Medical Journal, 8, pp.1234~1237 (2004)
- Skrobik YK, "Gottfied. Olanzapine vs haldol: treating delirium in critical setting", Intensive Care Med, 30, pp.444~449 (2004)
- 임현국, "섬망치료에 관한 올란자핀 근주와 할로페리돌 근주의 효과와 안정성에 대한 비교 연구", 대한정신약물학회지, 18(6), pp.423~428 (2007), 대한정신약물학회
- 이유진, "섬망 환자에서 Quetiapine과 Haloperidol의 치료 효과 비교 : 전향적, 무작위 연구", 생물정신의학, 16(1), pp.15~24 (2009), 대한생물정신의학회
- Prakanrattana U, "Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery", Anaesth Intensive Care, 35, pp.714~719 (2007)
- 최학규, "섬망의 치료에 대한 Quetiapine과 Haloperidol의 전향적 개방형 연구", 정신신체의학, 13(2), pp.85~94 (2005), 한국정신신체의학회
- 이준영, "섬망 치료에서 Aripiprazole과Haloperidol의 효과: 무작위 개방 연구", 생물치료정신의학, 13(2), pp.180~189 (2007), 대한생물치료정신의학회
- Straker DA, "Aripiprazole in the treatment of delirium", Psychosomatics, 47, pp.385~391 (2006)
- Lonergan E, "Antipsychotics for delirium", Cochrane database of Systematic Reviews, (1) (2009)
- "Antipsychotics, conventional and atypical"[URL]
- Pandharipande P, "Delirium: acute congnitive dysfunction in the critically ill", Curr Opin Crit Care, 11, pp.360~368 (2005)
- Centeno C, "Delirium in advanced cancer patients", Palliat Med, 18, pp.184~194 (2004)
- van Zyl LT, "Delirium concisely: condition is associated with increased morbidity, mortality, and length of hospitalization", Geriatrics, 61, pp.18~21 (2006)
- Attard A, "Delirium and its treatment", CNS Drugs, 22, pp.631~644 (2008)
- Morita T, "Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate", Support Care Cancer, 8, pp.134~137 (2000)
- Bourne RS, "Drug treatment of delirium: past, present and future", J Psychosom Res, 65, pp.273~282 (2008)
- Liptzin B, "Donepezil in the prevention and treatment of post-surgical delirium", Am J geriatr Pyshiatry, 13, pp.1100~1106 (2005)
- Sampson EL, "A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement", Int J Geriatr Psychiatry, 22, pp.343~349 (2007)
- Gamberini M, "Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial", Crit Care Med, 37, pp.1762~1768 (2009)
- Morita T, "Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients", J Pain Symptom Manage, 22, pp.997~1006 (2001)
- Metitieri T, "Delirium as a predictor of survival in older patients with advanced cancer", Arch Intern Med, 160, pp.2866~2868 (2000)
- Gagnon P, "Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring", J Pain Symptom Manage, 19, pp.412~426 (2000)
- Lawlor PG, "Occurrence, causes and outcome of delirium in patients with advanced cancer: a prospective study", Arch Intern Med, 160, pp.786~794 (2000)
- Sykes N, "Sedative use in the last week of life and the implications for end-of-life decision making", Arch Intern Med, 163, pp.341~344 (2003)
- Smith I, "An update on its clinical use", Anesthesiology, 81, pp.1005~1043 (1994)
